.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
QuintilesIMS
Covington
Fuji
McKesson
Novartis
Colorcon
Dow
Fish and Richardson
Farmers Insurance

Generated: December 17, 2017

DrugPatentWatch Database Preview

RETIN-A Drug Profile

« Back to Dashboard

Which patents cover Retin-a, and when can generic versions of Retin-a launch?

Retin-a is a drug marketed by Valeant Bermuda, Valeant Pharms North, and Valeant Intl. and is included in seven NDAs. There is one patent protecting this drug and two Paragraph IV challenges.

The generic ingredient in RETIN-A is tretinoin. There are twenty-four drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the tretinoin profile page.
Drug patent expirations by year for RETIN-A

Pharmacology for RETIN-A

Ingredient-typeRetinoids
Drug ClassRetinoid

Medical Subject Heading (MeSH) Categories for RETIN-A

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant BermudaRETIN-AtretinoinCREAM;TOPICAL019049-001Sep 16, 1988ABRXYesYes► Subscribe► Subscribe► Subscribe
Valeant IntlRETIN-AtretinoinSWAB;TOPICAL016921-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Valeant IntlRETIN-AtretinoinGEL;TOPICAL017955-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Valeant IntlRETIN-A MICROtretinoinGEL;TOPICAL020475-002May 10, 2002ABRXYesYes► Subscribe► Subscribe► Subscribe
Valeant BermudaRETIN-AtretinoinCREAM;TOPICAL017522-001Approved Prior to Jan 1, 1982AB1RXYesYes► Subscribe► Subscribe► Subscribe
Valeant Pharms NorthRETIN-AtretinoinCREAM;TOPICAL017340-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Valeant IntlRETIN-AtretinoinSOLUTION;TOPICAL016921-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Valeant IntlRETIN-AtretinoinGEL;TOPICAL017579-002Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Valeant IntlRETIN-A-MICROtretinoinGEL;TOPICAL020475-004Oct 23, 2017RXYesYes► Subscribe► Subscribe► Subscribe
Valeant IntlRETIN-A-MICROtretinoinGEL;TOPICAL020475-003Jan 28, 2014RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: RETIN-A

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant IntlRETIN-AtretinoinGEL;TOPICAL017955-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Valeant BermudaRETIN-AtretinoinCREAM;TOPICAL019049-001Sep 16, 1988► Subscribe► Subscribe
Valeant IntlRETIN-AtretinoinGEL;TOPICAL017955-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Valeant IntlRETIN-AtretinoinGEL;TOPICAL017579-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Valeant Pharms NorthRETIN-AtretinoinCREAM;TOPICAL017340-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Valeant BermudaRETIN-AtretinoinCREAM;TOPICAL017522-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Valeant IntlRETIN-AtretinoinGEL;TOPICAL017579-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Valeant Pharms NorthRETIN-AtretinoinCREAM;TOPICAL017340-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Valeant IntlRETIN-AtretinoinSOLUTION;TOPICAL016921-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Valeant BermudaRETIN-AtretinoinCREAM;TOPICAL017522-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for RETIN-A

Drugname Dosage Strength RLD Submissiondate
tretinoinGel0.04%Retin-A Micro12/20/2010
tretinoinGel0.1%Retin-A Micro7/8/2010

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Chubb
Teva
Express Scripts
Cerilliant
US Department of Justice
Harvard Business School
Daiichi Sankyo
Novartis
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot